173 related articles for article (PubMed ID: 15792855)
1. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
Williams RS; Green R; Glover JN
Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
5. Thermal and chemical denaturation of the BRCT functional module of human 53BP1.
Thanassoulas A; Nomikos M; Theodoridou M; Stavros P; Mastellos D; Nounesis G
Int J Biol Macromol; 2011 Oct; 49(3):297-304. PubMed ID: 21600917
[TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
7. The BRCT domain is a phospho-protein binding domain.
Yu X; Chini CC; He M; Mer G; Chen J
Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
[TBL] [Abstract][Full Text] [Related]
9. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
[TBL] [Abstract][Full Text] [Related]
10. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
[TBL] [Abstract][Full Text] [Related]
11. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
Gough CA; Gojobori T; Imanishi T
Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1.
Ekblad CM; Wilkinson HR; Schymkowitz JW; Rousseau F; Freund SM; Itzhaki LS
J Mol Biol; 2002 Jul; 320(3):431-42. PubMed ID: 12096901
[TBL] [Abstract][Full Text] [Related]
15. Thermal unfolding of human BRCA1 BRCT-domain variants.
Nikolopoulos G; Pyrpassopoulos S; Thanassoulas A; Klimentzou P; Zikos C; Vlassi M; Vorgias CE; Yannoukakos D; Nounesis G
Biochim Biophys Acta; 2007 Jun; 1774(6):772-80. PubMed ID: 17493881
[TBL] [Abstract][Full Text] [Related]
16. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
[TBL] [Abstract][Full Text] [Related]
17. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
Williams RS; Glover JN
J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738
[TBL] [Abstract][Full Text] [Related]
18. Cancer predisposing mutations in BRCT domains.
di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
[TBL] [Abstract][Full Text] [Related]
19. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA.
Yamane K; Tsuruo T
Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869
[TBL] [Abstract][Full Text] [Related]
20. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]